These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24954857)

  • 1. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
    Linnskog R; Jönsson G; Axelsson L; Prasad CP; Andersson T
    Mol Oncol; 2014 Dec; 8(8):1365-78. PubMed ID: 24954857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
    Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
    Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
    Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells.
    Xia Y; Khoi PN; Yoon HJ; Lian S; Joo YE; Chay KO; Kim KK; Jung YD
    Mol Cell Biochem; 2015 Jan; 398(1-2):147-56. PubMed ID: 25234193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion.
    Linnskog R; Mohapatra P; Moradi F; Prasad CP; Andersson T
    Oncotarget; 2016 Jun; 7(25):37790-37802. PubMed ID: 27191257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
    Ekström EJ; Sherwood V; Andersson T
    PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375.
    Itoh S; Hattori T; Hayashi H; Mizutani Y; Todo M; Takii T; Yang D; Lee JC; Matsufuji S; Murakami Y; Chiba T; Onozaki K
    J Immunol; 1999 Jun; 162(12):7434-40. PubMed ID: 10358197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways.
    Ip WK; Wong CK; Lam CW
    Clin Exp Immunol; 2006 Jul; 145(1):162-72. PubMed ID: 16792687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
    Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR4 mediates MAPK-STAT3 axis activation in bladder epithelial cells.
    Ying H; Da L; Yu-xiu S; Yu X; Li-xia L; Li-mei X; Wei-dong R
    Inflammation; 2013 Oct; 36(5):1064-74. PubMed ID: 23612802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
    Anastas JN; Kulikauskas RM; Tamir T; Rizos H; Long GV; von Euw EM; Yang PT; Chen HW; Haydu L; Toroni RA; Lucero OM; Chien AJ; Moon RT
    J Clin Invest; 2014 Jul; 124(7):2877-90. PubMed ID: 24865425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
    Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology.
    Ng DC; Long CS; Bogoyevitch MA
    J Biol Chem; 2001 Aug; 276(31):29490-8. PubMed ID: 11382751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells.
    Mohapatra P; Prasad CP; Andersson T
    Mol Oncol; 2019 Feb; 13(2):480-494. PubMed ID: 30582770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5A activates the calpain-mediated cleavage of filamin A.
    O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
    J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.
    Jin Z; Zhao C; Han X; Han Y
    BMC Cancer; 2012 Oct; 12():480. PubMed ID: 23075330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt5a promotes inflammatory responses via nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells.
    Zhao Y; Wang CL; Li RM; Hui TQ; Su YY; Yuan Q; Zhou XD; Ye L
    J Biol Chem; 2014 Jul; 289(30):21028-39. PubMed ID: 24891513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway.
    Ma L; Wang HY
    J Biol Chem; 2007 Sep; 282(39):28980-28990. PubMed ID: 17684012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.